Episode 108 - JPM Special - Dirk Thye, CEO Quince Therapeutics episode artwork

EPISODE · Jan 26, 2026 · 11 MIN

Episode 108 - JPM Special - Dirk Thye, CEO Quince Therapeutics

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

In our first JPM Special 2026, we’re joined by Dirk Thye, CEO of Quince Therapeutics, as the company approaches a defining Phase 3 readout. A candid conversation about high-stakes data, leadership under pressure, and what a true do-or-die moment looks like in biotech.

NOW PLAYING

Episode 108 - JPM Special - Dirk Thye, CEO Quince Therapeutics

0:00 11:47

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 11 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on January 26, 2026.

What is this episode about?

In our first JPM Special 2026, we’re joined by Dirk Thye, CEO of Quince Therapeutics, as the company approaches a defining Phase 3 readout. A candid conversation about high-stakes data, leadership under pressure, and what a true do-or-die moment...

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!